Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Other Working Capital Changes (2016 - 2025)

BioCorRx's Other Working Capital Changes history spans 15 years, with the latest figure at $9716.0 for Q2 2025.

  • For Q2 2025, Other Working Capital Changes fell 74.85% year-over-year to $9716.0; the TTM value through Jun 2025 reached -$13063.0, up 93.99%, while the annual FY2024 figure was -$4045.0, 148.54% down from the prior year.
  • Other Working Capital Changes for Q2 2025 was $9716.0 at BioCorRx, up from -$9716.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $127377.0 in Q4 2021 and bottomed at -$192587.0 in Q4 2023.
  • The 5-year median for Other Working Capital Changes is -$9716.0 (2025), against an average of -$11352.5.
  • The largest annual shift saw Other Working Capital Changes crashed 1092.49% in 2023 before it soared 363.56% in 2024.
  • A 5-year view of Other Working Capital Changes shows it stood at $127377.0 in 2021, then tumbled by 112.68% to -$16150.0 in 2022, then plummeted by 1092.49% to -$192587.0 in 2023, then skyrocketed by 93.22% to -$13063.0 in 2024, then soared by 174.38% to $9716.0 in 2025.
  • Per Business Quant, the three most recent readings for BICX's Other Working Capital Changes are $9716.0 (Q2 2025), -$9716.0 (Q1 2025), and -$13063.0 (Q3 2024).